2 exciting ETFs named as buys by experts

Here are two ETFs that could be buys…

| More on:
A young woman sits with her hand to her chin staring off to the side thinking about her investments.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to buy some exchange traded funds (ETFs), then you certainly have a lot of options.

But which ones could be buys? Two that have been tipped as buys by analysts are listed below. Here's what they are saying about them:

ETFS Battery Tech & Lithium ETF (ASX: ACDC)

If you're wanting to get some exposure to the decarbonisation megatrend, then the ETFS Battery Tech & Lithium ETF could be one way to do it.

This popular ETF allows investors to buy a slice of companies involved in battery technology, electric vehicles, and lithium mining. This includes BYD, Mineral Resources Limited (ASX: MIN), Pilbara Minerals Ltd (ASX: PLS), Nissan, and Renault.

Jessica Amir from Saxo Markets is positive on the ETF. Especially for investors that aren't keen on stock picking in the lithium sector. She commented:

If stock picking is not for you, and if you believe, like we do, that the electric vehicle industry and the critical minerals/ commodities will continue to see rising demand, and policy support, and also benefit from the world striving to be carbon neutral by 2050, then you could invest or trade in Global X Lithium & Battery Tech ETF (LIT) or ETFS Battery Tech & Lithium ETF (ACDC) that invests in about 30 of the biggest EV and battery technology companies in the world.

ETFS S&P Biotech ETF (ASX: CURE)

Another ETF that has been tipped as a buy is the ETFS S&P Biotech ETF. As its name implies, this ETF gives investors access to U.S. healthcare biotechnology companies.

The fund manager notes that these companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.

Among its largest holdings are ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.

Felicity Thomas from Shaw & Partners is a fan of the ETF. She recently told Livewire:

I like to buy ETFs for the long term. We have an ageing population, and what's the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that's where you want to be invested over the next couple of decades.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

A young female investor with brown curly hair and wearing a yellow top and glasses sits at her desk using her calculator to work out how much her ASX dividend shares will pay this year
ETFs

How to build wealth with ASX ETFs

These funds could help you build wealth over the long term.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Dividend Investing

This ASX income ETF is trading on a 7% yield right now

You'd be hard pressed to find a stock that matches this yield...

Read more »

A man is shocked about the explosion happening out of his brain.
ETFs

These 2 ASX ETFs are booming as the silver and copper price smash new records

New all-time highs.

Read more »

A couple cheers as they sit on their lounge looking at their laptop and reading about the rising Redbubble share price
ETFs

Where to invest $10,000 in ASX ETFs for 2026

These funds offer investors exposure to exciting stocks from across the world.

Read more »

a person stands arms outstretched on the top of a mountain with a beautiful sunrise in the sky
ETFs

3 Australian ETFs to buy and hold forever

These ETFs might never go out of style.

Read more »

Excited couple celebrating success while looking at smartphone.
ETFs

3 stellar ASX ETFs for growth investors to buy in 2026

Looking to build wealth with ASX ETFs? Here are three to consider.

Read more »

ETF written in yellow with a yellow underline and the full word spelt out in white underneath.
ETFs

3 excellent ASX ETFs to buy with $3,000 in December

Got money to invest? These funds could be worth considering this month.

Read more »

A couple cheers as they sit on their lounge looking at their laptop and reading about the rising Redbubble share price
ETFs

3 reasons to buy the Betashares Nasdaq 100 ETF (NDQ) ETF in 2026

This fund could be up there as one of the best to buy for 2026 and beyond.

Read more »